Otsuka (OTCMKTS:OTSKY) Trading 10.6% Higher – Time to Buy?

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY)’s stock price shot up 10.6% on Tuesday . The company traded as high as $38.20 and last traded at $38.05. 589 shares traded hands during trading, a decline of 99% from the average daily volume of 40,075 shares. The stock had previously closed at $34.4080.

Otsuka Stock Up 4.5%

The company has a current ratio of 2.17, a quick ratio of 1.67 and a debt-to-equity ratio of 0.05. The company has a market capitalization of $40.77 billion, a P/E ratio of 15.24, a PEG ratio of 7.60 and a beta of -0.04. The firm’s 50 day moving average price is $34.14 and its two-hundred day moving average price is $33.60.

Otsuka (OTCMKTS:OTSKY) last announced its quarterly earnings data on Friday, July 31st. The company reported $0.70 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.19. Otsuka had a net margin of 15.50% and a return on equity of 12.93%. The business had revenue of $4.41 billion for the quarter, compared to analyst estimates of $3.95 billion. Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. Equities research analysts forecast that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 1.96 EPS for the current year.

Otsuka Company Profile

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.